News
A group of experts who advise the US Food and Drug Administration on its vaccine decisions voted unanimously Thursday to make ...
The FDA will limit the vaccine’s availability later this year to older adults and those who may be at risk of severe illness.
Advisers to the Food and Drug Administration met Thursday to help decide which variant of the virus that causes COVID should ...
Italian tyre maker Pirelli is in a risky situation after its Chinese leading shareholder Sinochem rejected a proposal by the ...
Healthy younger adults and children will no longer be automatically approved for annual COVID-19 vaccines under a new policy ...
The change marks a shift in the Food and Drug Administration’s policy on approving COVID-19 vaccines, which the new ...
Seattle vaccine experts were confused by the country's apparent new direction around updated COVID-19 shots, which top FDA ...
The agency narrowed who can get the shot and added new study requirements that could cost the company tens of millions.
A group of experts who advise the US Food and Drug Administration on its vaccine decisions voted unanimously Thursday to make a broad recommendation about which lineage of the coronavirus should b ...
The restrictions on Novavax's vaccine could portend changes at the FDA. Commissioner Marty Makary suggested last week that ...
The U.S. Food and Drug Administration approved Novavax’s Covid-19 vaccine, but limited its use to older adults and people over the age of 12 with conditions that put them at risk due to the illness.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results